Skip to main content
. 2022 Aug 10;23(9):e13641. doi: 10.1002/acm2.13641
# Objective Tolerances In Report
1‐2 QMP understands algorithms has received proper training
2 Develop schedule to acquire data, model and verify the dose algorithms
3 Consult manufacturer's guidance for data acquisition
3.A Verify operation, calibration of measurement equipment
3.B Acquire appropriate CT calibration data
3.C Review detector and corrections needs for small field measurements
3.D Review raw data (compare with published data, check for error, confirm import into TPS)
4 Model per manufacturer's instructions, compare to published data for same machine/TPS
5.1 Verify that TPS reproduces the absolute dose under reference calibration conditions 0.5%
5.2 Compare calculated dose in clinical planning module to calculated dose in physics module Within statistical, grid size, and material definition uncertainty
5.3 Perform spot checks comparing calculated dose in clinical planning module to commissioning data 2%
5.4 Small static (non‐SRS) MLC‐shaped fields

2% in high dose region (one parameter change)

5% in high dose region (multiple parameters)

2 mm in penumbra

3% of max dose in low dose tail (up to 5 cm from field edge)

5.5 MLC transmission, leaf overtravel, output factor effects
5.6 Off axis modelling including primary collimator
5.7 Field divergence and depth dose changes with SSD
5.8 Oblique surface incidence
6.1 Validate planning system reported electron (or mass) densities against known values
6.2 Heterogeneity correction distal to lung tissue 3%
7.1 Verify small field PDD

2% of prescribed dose with ion chamber in low‐gradient region

3% of prescribed dose with ion chamber in high‐gradient region

Evaluate planar/volumetric results at 2% local/2mm, pre‐treatment QA should pass >95% using 3% global/2mm and 10% threshold

5% of prescribed dose with end‐to‐end tests in low‐gradient region

7.2 Verify output for small MLC‐defined fields
7.3 TG‐119 tests
7.4 Clinical tests
7.5 External review
8.1 Verify the TPS reproduces the absolute dose under reference calibration conditions for electron energies 0.5%
8.2 Basic electron model verification with shaped fields 3%/3 mm
8.3 Electron surface irregularities/obliquity 5%
8.4 Electron inhomogeneity test 7%
9 Routine QA established, including baseline QA plan(s) identified for each configured beam